Drugs that contain Fenofibric Acid
1. Fibricor patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7569612 | ATHENA | Methods of use of fenofibric acid |
Aug, 2027
(3 years from now) | |
| US7741373 | ATHENA | Methods of use of fenofibric acid |
Aug, 2027
(3 years from now) | |
| US7741374 | ATHENA | Methods of use of fenofibric acid |
Aug, 2027
(3 years from now) | |
| US7915247 | ATHENA | Methods of use of fenofibric acid |
Aug, 2027
(3 years from now) | |
Market Authorisation Date: 14 August, 2009
Treatment: Adjunctive therapy to diet in patients with hyperlipidemias; Adjunctive therapy to diet to patients with hypertriglyceridemia; Adjunctive therapy to diet in patients with elevated cholesterol and/or l...
Dosage: TABLET;ORAL
More Information on Dosage
FIBRICOR family patents
